News | August 06, 2025
Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr
Cenexi reports an EBITDA breakeven for the quarter
Cenexi reports an EBITDA breakeven for the quarter
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
This will be Aster’s fifth hospital in Bengaluru
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Subscribe To Our Newsletter & Stay Updated
